Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome

BackgroundCongenital long-QT syndrome (LQTS) is a major cause of sudden cardiac death (SCD) in young individuals, calling for sophisticated risk assessment. Risk stratification, however, is challenging as the individual arrhythmic risk varies pronouncedly, even in individuals carrying the same varia...

Full description

Bibliographic Details
Main Authors: Marina Rieder, Paul Kreifels, Judith Stuplich, David Ziupa, Helge Servatius, Luisa Nicolai, Alessandro Castiglione, Christiane Zweier, Babken Asatryan, Katja E. Odening
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.916036/full
_version_ 1797867196093825024
author Marina Rieder
Paul Kreifels
Judith Stuplich
David Ziupa
Helge Servatius
Luisa Nicolai
Alessandro Castiglione
Christiane Zweier
Babken Asatryan
Katja E. Odening
Katja E. Odening
author_facet Marina Rieder
Paul Kreifels
Judith Stuplich
David Ziupa
Helge Servatius
Luisa Nicolai
Alessandro Castiglione
Christiane Zweier
Babken Asatryan
Katja E. Odening
Katja E. Odening
author_sort Marina Rieder
collection DOAJ
description BackgroundCongenital long-QT syndrome (LQTS) is a major cause of sudden cardiac death (SCD) in young individuals, calling for sophisticated risk assessment. Risk stratification, however, is challenging as the individual arrhythmic risk varies pronouncedly, even in individuals carrying the same variant.Materials and MethodsIn this study, we aimed to assess the association of different electrical parameters with the genotype and the symptoms in patients with LQTS. In addition to the heart-rate corrected QT interval (QTc), markers for regional electrical heterogeneity, such as QT dispersion (QTmax-QTmin in all ECG leads) and delta Tpeak/end (Tpeak/end V5 – Tpeak/end V2), were assessed in the 12-lead ECG at rest and during exercise testing.ResultsQTc at rest was significantly longer in symptomatic than asymptomatic patients with LQT2 (493.4 ms ± 46.5 ms vs. 419.5 ms ± 28.6 ms, p = 0.004), but surprisingly not associated with symptoms in LQT1. In contrast, post-exercise QTc (minute 4 of recovery) was significantly longer in symptomatic than asymptomatic patients with LQT1 (486.5 ms ± 7.0 ms vs. 463.3 ms ± 16.3 ms, p = 0.04), while no such difference was observed in patients with LQT2. Enhanced delta Tpeak/end and QT dispersion were only associated with symptoms in LQT1 (delta Tpeak/end 19.0 ms ± 18.1 ms vs. −4.0 ms ± 4.4 ms, p = 0.02; QT-dispersion: 54.3 ms ± 10.2 ms vs. 31.4 ms ± 10.4 ms, p = 0.01), but not in LQT2. Delta Tpeak/end was particularly discriminative after exercise, where all symptomatic patients with LQT1 had positive and all asymptomatic LQT1 patients had negative values (11.8 ± 7.9 ms vs. −7.5 ± 1.7 ms, p = 0.003).ConclusionDifferent electrical parameters can distinguish between symptomatic and asymptomatic patients in different genetic forms of LQTS. While the classical “QTc at rest” was only associated with symptoms in LQT2, post-exercise QTc helped distinguish between symptomatic and asymptomatic patients with LQT1. Enhanced regional electrical heterogeneity was only associated with symptoms in LQT1, but not in LQT2. Our findings indicate that genotype-specific risk stratification approaches based on electrical parameters could help to optimize risk assessment in LQTS.
first_indexed 2024-04-09T23:36:28Z
format Article
id doaj.art-a7ec6a5adbf2435fa5a35fa786ea9d82
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-09T23:36:28Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-a7ec6a5adbf2435fa5a35fa786ea9d822023-03-20T10:23:40ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-07-01910.3389/fcvm.2022.916036916036Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT SyndromeMarina Rieder0Paul Kreifels1Judith Stuplich2David Ziupa3Helge Servatius4Luisa Nicolai5Alessandro Castiglione6Christiane Zweier7Babken Asatryan8Katja E. Odening9Katja E. Odening10Translational Cardiology, Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, SwitzerlandDepartment of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg-Bad Krozingen, University of Freiburg, Freiburg, GermanyDepartment of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg-Bad Krozingen, University of Freiburg, Freiburg, GermanyDepartment of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg-Bad Krozingen, University of Freiburg, Freiburg, GermanyTranslational Cardiology, Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, SwitzerlandTranslational Cardiology, Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, SwitzerlandTranslational Cardiology, Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, SwitzerlandDepartment of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandTranslational Cardiology, Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, SwitzerlandTranslational Cardiology, Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, SwitzerlandDepartment of Physiology, University of Bern, Bern, SwitzerlandBackgroundCongenital long-QT syndrome (LQTS) is a major cause of sudden cardiac death (SCD) in young individuals, calling for sophisticated risk assessment. Risk stratification, however, is challenging as the individual arrhythmic risk varies pronouncedly, even in individuals carrying the same variant.Materials and MethodsIn this study, we aimed to assess the association of different electrical parameters with the genotype and the symptoms in patients with LQTS. In addition to the heart-rate corrected QT interval (QTc), markers for regional electrical heterogeneity, such as QT dispersion (QTmax-QTmin in all ECG leads) and delta Tpeak/end (Tpeak/end V5 – Tpeak/end V2), were assessed in the 12-lead ECG at rest and during exercise testing.ResultsQTc at rest was significantly longer in symptomatic than asymptomatic patients with LQT2 (493.4 ms ± 46.5 ms vs. 419.5 ms ± 28.6 ms, p = 0.004), but surprisingly not associated with symptoms in LQT1. In contrast, post-exercise QTc (minute 4 of recovery) was significantly longer in symptomatic than asymptomatic patients with LQT1 (486.5 ms ± 7.0 ms vs. 463.3 ms ± 16.3 ms, p = 0.04), while no such difference was observed in patients with LQT2. Enhanced delta Tpeak/end and QT dispersion were only associated with symptoms in LQT1 (delta Tpeak/end 19.0 ms ± 18.1 ms vs. −4.0 ms ± 4.4 ms, p = 0.02; QT-dispersion: 54.3 ms ± 10.2 ms vs. 31.4 ms ± 10.4 ms, p = 0.01), but not in LQT2. Delta Tpeak/end was particularly discriminative after exercise, where all symptomatic patients with LQT1 had positive and all asymptomatic LQT1 patients had negative values (11.8 ± 7.9 ms vs. −7.5 ± 1.7 ms, p = 0.003).ConclusionDifferent electrical parameters can distinguish between symptomatic and asymptomatic patients in different genetic forms of LQTS. While the classical “QTc at rest” was only associated with symptoms in LQT2, post-exercise QTc helped distinguish between symptomatic and asymptomatic patients with LQT1. Enhanced regional electrical heterogeneity was only associated with symptoms in LQT1, but not in LQT2. Our findings indicate that genotype-specific risk stratification approaches based on electrical parameters could help to optimize risk assessment in LQTS.https://www.frontiersin.org/articles/10.3389/fcvm.2022.916036/fulllong-QT syndromegenetic arrhythmia disordersrisk stratificationQTcelectrocardiogram
spellingShingle Marina Rieder
Paul Kreifels
Judith Stuplich
David Ziupa
Helge Servatius
Luisa Nicolai
Alessandro Castiglione
Christiane Zweier
Babken Asatryan
Katja E. Odening
Katja E. Odening
Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
Frontiers in Cardiovascular Medicine
long-QT syndrome
genetic arrhythmia disorders
risk stratification
QTc
electrocardiogram
title Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
title_full Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
title_fullStr Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
title_full_unstemmed Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
title_short Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
title_sort genotype specific ecg based risk stratification approaches in patients with long qt syndrome
topic long-QT syndrome
genetic arrhythmia disorders
risk stratification
QTc
electrocardiogram
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.916036/full
work_keys_str_mv AT marinarieder genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT paulkreifels genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT judithstuplich genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT davidziupa genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT helgeservatius genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT luisanicolai genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT alessandrocastiglione genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT christianezweier genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT babkenasatryan genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT katjaeodening genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome
AT katjaeodening genotypespecificecgbasedriskstratificationapproachesinpatientswithlongqtsyndrome